Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.52 |
| ▸ | GABRA1 | P14867 | 9/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 9/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | CNR2 | P34972 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | CNR1 | P21554 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2050350 | 0.87 | XDH (0.54) | XDHGABRA1GABRB2ALDH1A1MAPT | |
| SCHEMBL9999649 | 0.82 | XDH (0.66) | XDHGABRA1GABRB2ALDH1A1MAPT | |
| SCHEMBL7846085 | 0.82 | XDH (0.48) | XDHGABRA1GABRB2ALDH1A1MAPT | |
| SCHEMBL29172017 | 0.81 | XDH (0.48) | XDHGABRA1GABRB2ALDH1A1MAPT | |
| SCHEMBL19248511 | 0.81 | XDH (0.48) | XDHGABRA1GABRB2ALDH1A1MAPT | |
| SCHEMBL4678573 | 0.81 | XDH (0.48) | XDHGABRA1GABRB2ALDH1A1MAPT | |
| SCHEMBL8257640 | 0.78 | GABRA1 (0.40) | XDHGABRA1GABRB2ALDH1A1MAPT | |
| SCHEMBL14693998 | 0.78 | GABRA1 (0.45) | XDHGABRA1GABRB2ALDH1A1MAPT | |
| SCHEMBL821126 | 0.78 | GABRA1 (0.72) | XDHGABRA1GABRB2ALDH1A1MAPT | |
| SCHEMBL1006107 | 0.78 | XDH (0.70) | XDHGABRA1GABRB2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180093939-A9 | NOVEL MONOMERS FROM BIOMASS | NDSU RESEARCH FOUNDATION (US) | 2018-04-05 | — | — | US | disclosed |
| US-20170233325-A1 | NOVEL MONOMERS FROM BIOMASS | NDSU RESEARCH FOUNDATION (US) | 2017-08-17 | — | — | US | disclosed |
| EP-1340271-A2 | BROADBAND LIGHT-EMITTING POLYMERIC DIODES (PLED) | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2003-09-03 | — | — | EP | disclosed |
| WO-2002045185-A2 | BROADBAND LIGHT-EMITTING POLYMERIC DIODES (PLED) | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2002-06-06 | — | — | WO | disclosed |
| US-4801735-A | LEUKOTRIENE INHIBITORS | LILLY INDUSTRIES LIMITED (GB) | 1989-01-31 | — | — | US | disclosed |
| EP-0183532-A2 | Pharmaceutical compounds | Lilly Industries Limited (GB) | 1986-06-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180093939-A9 | NOVEL MONOMERS FROM BIOMASS | DCXR, MANBA, PGLS | XDH 1936/4885GABRA1 4311/4885GABRB2 3588/4885 |
| US-20170233325-A1 | NOVEL MONOMERS FROM BIOMASS | DCXR, MANBA, PGLS | XDH 1936/4885GABRA1 4311/4885GABRB2 3588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.